Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) shares surged 10.59 percent to close at $11.38 a share Monday. The stock traded between $10.42 and $11.40 on volume of 1.06 million shares traded. The company has recently been added to the Russell 3000 Index and the Russell Global Index. Shares of AcelRx Pharmaceuticals have gained approximately 167.0 percent year-to-date.
Get more information on AcelRx Pharmaceuticals and free access to the in-depth equity report at:
Anacor Pharmaceuticals Inc. (NASDAQ: ANAC) shares spiked 11.01 percent to close at $6.25 a share Monday. The stock traded between $5.47 and $6.50 on volume of 633,820 shares traded. The company is scheduled to present at the JMP Securities Healthcare Conference on Wednesday, July 10, 2013. Shares of Anacor Pharmaceuticals are up approximately 20.0 percent year-to-date.
Get more information on Anacor Pharmaceuticals and free access to the in-depth equity report at:
Dot Hill Systems Corp. (NASDAQ: HILL) shares increased 12.84 percent to close at $2.46 a share Monday. The stock traded between $2.24 and $2.49 on volume of 982,591 shares traded. Zacks Investment Research has recently upgraded the company to a strong buy. Shares of Dot Hill Systems have gained approximately 162.0 percent year-to-date.
Get more information on Dot Hill Systems and free access to the in-depth equity report at:
The Jones Group Inc. (NYSE: JNY) shares gained 7.58 percent to close at $15.75 a share Monday. The stock traded between $14.71 and $17.00 on volume of 5.46 million shares traded. According to various reports the company has hired Citigroup to help explore the possible sale of all or part of the company. Shares of the Jones Group have gained approximately 42.4 percent year-to-date.
Get more information on The Jones Group and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities